Positron emission tomography and histopathology in Creutzfeldt-Jakob disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8414042.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We studied a 62-year-old man with Creutzfeldt-Jakob disease (CJD), using positron emission tomography (PET) and (18F)-2-fluoro-2-deoxy-D-glucose (FDG). Glucose metabolism was heterogeneously decreased throughout the brain. At autopsy, regional distributions of spongiosis, astrogliosis, and neuronal loss correlated with premortem regional metabolic deficits. These results suggest that PET with FDG may provide metabolic regional markers for CJD neuropathology.
Medical subject headings
- Brain
- Creutzfeldt-Jakob Syndrome
- Tomography, Emission-Computed